Bioengineers and Biomedical Engineers in San Francisco-Oakland-Fremont, CA
Employers filed 112 applications covering 112 positions for this role here, at a median of $145,000 a year. 57 of those state a minimum and no maximum — a Labor Condition Application commits an employer to a floor, not to a salary.
What the government requires here
The prevailing wage for Bioengineers and Biomedical Engineers in San Francisco-Oakland-Fremont, CA, wage year 2025-26 — the four levels an employer must meet depending on the experience the role demands.
| Level | Who it is for | A year |
|---|---|---|
| Level I | Entry: a role needing basic understanding and close supervision | $103,771 |
| Level II | Qualified: some experience, moderate supervision | $121,264 |
| Level III | Experienced: sound understanding, limited supervision | $138,778 |
| Level IV | Fully competent: judgement, may supervise others | $156,270 |
Who filed, and at what
| Employer | Level | Filings | Positions | Median |
|---|---|---|---|---|
| 10x Genomics, Inc. | Level IV | 7 | 7 | $170,000 |
| Labs for Humanity, Inc. | Level IV | 6 | 6 | $215,000 |
| ABBOTT DIABETES CARE INC. | Level III | 3 | 3 | $139,000 |
| BillionToOne, Inc. | Level I | 2 | 2 | $107,326 |
| Insight Rx, Inc. | Level IV | 2 | 2 | $165,000 |
| Labs for Humanity, Inc. | Level II | 2 | 2 | $123,271 |
| Neuralink Corp. | Level III | 2 | 2 | $138,778 |
| Penumbra, Inc. | Level III | 2 | 2 | $138,778 |
| Pheast Therapeutics, Inc | Level II | 2 | 2 | $156,270 |
| ABBOTT DIABETES CARE INC. | Level I | 1 | 1 | $105,000 |
| ABBOTT DIABETES CARE INC. | Level II | 1 | 1 | $125,000 |
| Adialante LLC | Level III | 1 | 1 | $150,000 |
| Bayer HealthCare LLC | Level IV | 1 | 1 | $168,000 |
| Bayone Solutions, Inc. | Level II | 1 | 1 | $121,264 |
| Bristol-Myers Squibb Company | Level III | 1 | 1 | $159,305 |
| Calico Life Sciences LLC | Level III | 1 | 1 | $142,000 |
| Calyxo, Inc. | Level III | 1 | 1 | $140,000 |
| CarbonDrop, Inc. | Level I | 1 | 1 | $105,000 |
| Cerus Corporation | Level III | 1 | 1 | $146,120 |
| EVALVE, INC. | Level IV | 1 | 1 | $156,270 |
| Exact Sciences Corporation | Level IV | 1 | 1 | $186,275 |
| Freenome Holdings, Inc. | Level II | 1 | 1 | $121,264 |
| Fresenius USA, Inc., a Fresenius Medical Care N.A. company | Level IV | 1 | 1 | $175,000 |
| GE PRECISION HEALTHCARE LLC | Level IV | 1 | 1 | $212,200 |
| Genentech, Inc. | Level III | 1 | 1 | $138,778 |
| Gilead Sciences, Inc. | Level III | 1 | 1 | $171,360 |
| Glyphic Biotechnologies, Inc. | Level III | 1 | 1 | $140,000 |
| Hinge Health, Inc. | Level III | 1 | 1 | $168,000 |
| Instance, Inc. | Level III | 1 | 1 | $147,250 |
| LINGO US INC. | Level II | 1 | 1 | $130,000 |
| Mendaera, Inc. | Level II | 1 | 1 | $130,000 |
| Mizuho Orthopedic Systems, Inc. | Level IV | 1 | 1 | $160,515 |
| Natera, Inc. | Level IV | 1 | 1 | $191,500 |
| Nautilus Subsidiary, Inc | Level III | 1 | 1 | $145,000 |
| Nevro Corp | Level II | 1 | 1 | $159,097 |
| Noah Medical Corporation | Level III | 1 | 1 | $185,400 |
| Noah Medical Corporation | Level IV | 1 | 1 | $185,400 |
| OuraRing Inc. | Level IV | 1 | 1 | $172,550 |
| Penumbra, Inc. | Level I | 1 | 1 | $103,771 |
| Penumbra, Inc. | Level II | 1 | 1 | $121,264 |
| Prellis Biologics Inc. | Level II | 1 | 1 | $121,264 |
| Promaxo, Inc. | Level III | 1 | 1 | $156,270 |
| Promaxo, Inc. | Level IV | 1 | 1 | $160,000 |
| Q Bio, Inc. | Level IV | 1 | 1 | $160,000 |
| Route 92 Medical, Inc. | Level III | 1 | 1 | $140,000 |
| Science Corporation | Level II | 1 | 1 | $185,000 |
| Stryker Corporation | Level III | 1 | 1 | $138,778 |
| THINK Surgical, Inc. | Level III | 1 | 1 | $139,203 |
| Trinity Consultants, Inc. | Level II | 1 | 1 | $121,264 |
| Triple Ring Technologies, Inc. | Level IV | 1 | 1 | $156,270 |
| Twist Bioscience Corporation | Level I | 1 | 1 | $103,771 |
| Twist Bioscience Corporation | Level IV | 1 | 1 | $180,000 |
| ULTIMA GENOMICS, INC. | Level III | 1 | 1 | $138,778 |
| Verana Health, Inc. | Level II | 1 | 1 | $141,441 |
| Vessel Sciences Inc. | Level II | 1 | 1 | $185,000 |
| XII Medical, Inc. | Level IV | 1 | 1 | $156,270 |
| Yosemite Management, LLC | Level IV | 1 | 1 | $156,270 |
| CORPORATE SOLUTIONS GENERAL INC | Level III | 1 | 1 | $166,400 |
| Illumina, Inc. | Level I | 1 | 1 | $120,000 |
| Mendaera, Inc. | Level IV | 1 | 1 | $160,000 |
| Penumbra, Inc. | Level IV | 1 | 1 | $150,571 |
| RefleXion Medical, Inc. | Level III | 1 | 1 | $140,000 |
| Benchling, Inc. | Level III | 1 | 1 | $135,000 |
| Neptune Medical, Inc. | Level I | 1 | 1 | $100,000 |
| XII Medical, Inc. | Level IV | 1 | 1 | $148,408 |
| Advanced Cell Diagnostics, Inc. | Level III | 1 | 1 | $118,976 |
| University of California, San Francisco | not stated | 19 | 19 | $79,881 |
| University of California, Berkeley | not stated | 6 | 6 | $83,918 |
| Gilead Sciences, Inc | not stated | 1 | 1 | $127,520 |
| Lawrence Berkeley National Laboratory | not stated | 1 | 1 | $79,332 |
Tell me when this moves
One email when the prevailing wage for Bioengineers and Biomedical Engineers in San Francisco-Oakland-Fremont, CA changes — the library turns over every July, and what an employer must offer changes with it.
Source: OFLC disclosure data and prevailing wage library, US Department of Labor (public domain). Figures are what employers filed, not what they paid.